One Dose Trial Data – DoriS Trial Results

This presentation highlights the growing body of strong evidence supporting single-dose HPV vaccination, based on both observational studies (Costa Rica, India) and randomized trials such as the DORIS study in Tanzania. Results show that a single dose elicits immune responses comparable to two or three doses, with stable antibody levels lasting over 10 years and […]

HPV vaccine delivery strategy in Tanzania – Towards sustainable delivery platforms and coverage

The HPV vaccination program in Tanzania evolved from a demonstration in 2014 to national introduction in 2018 and further integration into adolescent sexual and reproductive health services through the HPV-Plus strategy. This approach, combining school-based and facility-based delivery, significantly improved uptake, particularly for HPV2. Sustaining coverage relies on strong linkages between schools, health facilities, and […]

>